These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 27884546)
1. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)]. Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546 [TBL] [Abstract][Full Text] [Related]
2. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. Alkawas AA; Shahien EA; Hussein AM J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624 [TBL] [Abstract][Full Text] [Related]
3. [Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion]. Kabesha TB; Glacet-Bernard A; Rostaqui O; Souied EH J Fr Ophtalmol; 2015 May; 38(5):414-20. PubMed ID: 25956562 [TBL] [Abstract][Full Text] [Related]
4. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab. Wittström E; Holmberg H; Hvarfner C; Andréasson S Eur J Ophthalmol; 2012; 22(4):563-74. PubMed ID: 22139613 [TBL] [Abstract][Full Text] [Related]
5. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma. Batioğlu F; Astam N; Ozmert E Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643 [TBL] [Abstract][Full Text] [Related]
7. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases]. Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433 [TBL] [Abstract][Full Text] [Related]
8. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739 [TBL] [Abstract][Full Text] [Related]
9. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786 [TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma. Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201 [TBL] [Abstract][Full Text] [Related]
11. Intraocular pressure following combined routes of bevacizumab-augmented trabeculectomy for refractory neovascular glaucoma. Chatterjee S; Rao A Semin Ophthalmol; 2013 Mar; 28(2):72-4. PubMed ID: 23448559 [TBL] [Abstract][Full Text] [Related]
12. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma. Kitnarong N; Chindasub P; Metheetrairut A Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438 [TBL] [Abstract][Full Text] [Related]
13. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma. Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590 [TBL] [Abstract][Full Text] [Related]
15. Bevacizumab as adjuvant for neovascular glaucoma. Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641 [TBL] [Abstract][Full Text] [Related]
16. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma. Gupta V; Jha R; Rao A; Kong G; Sihota R Eur J Ophthalmol; 2009; 19(3):435-41. PubMed ID: 19396791 [TBL] [Abstract][Full Text] [Related]
17. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma. Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888 [TBL] [Abstract][Full Text] [Related]
18. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab. Fong AW; Lee GA; O'Rourke P; Thomas R Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900 [TBL] [Abstract][Full Text] [Related]
19. Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma. Higashide T; Murotani E; Saito Y; Ohkubo S; Sugiyama K Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):603-10. PubMed ID: 22116499 [TBL] [Abstract][Full Text] [Related]
20. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]